Organon & Co (OGN)
21.54
+0.19
(+0.89%)
USD |
NYSE |
May 15, 15:21
Organon Total Assets (Quarterly): 11.89B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 11.89B |
December 31, 2023 | 12.06B |
September 30, 2023 | 11.01B |
June 30, 2023 | 10.98B |
March 31, 2023 | 10.76B |
December 31, 2022 | 10.96B |
September 30, 2022 | 10.44B |
Date | Value |
---|---|
June 30, 2022 | 10.61B |
March 31, 2022 | 10.60B |
December 31, 2021 | 10.68B |
September 30, 2021 | 11.34B |
June 30, 2021 | 10.91B |
March 31, 2021 | 9.642B |
December 31, 2020 | 10.11B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
9.642B
Minimum
Mar 2021
12.06B
Maximum
Dec 2023
10.86B
Average
10.84B
Median
Total Assets (Quarterly) Benchmarks
Amgen Inc | 92.98B |
Merck & Co Inc | 105.85B |
Pfizer Inc | 221.10B |
Alnylam Pharmaceuticals Inc | 3.824B |
Moderna Inc | 16.73B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 11.84B |
Shareholders Equity (Quarterly) | 48.00M |
Debt to Equity Ratio | 181.54 |
Current Ratio | 1.649 |
Net Debt Paydown Yield | 0.83% |